Logo

H. Lee Moffitt Cancer Licenses Rosetta's Resolver

Dec 04, 2006
NEW YORK (GenomeWeb News) — The H. Lee Moffitt Cancer and Research Institute has licensed Rosetta Biosoftware’s Resolver software, Rosetta said today.
 
The Moffitt Institute, based in Tampa, Fla., will use the software to handle and analyze data generated by the Total Cancer Care program to help identify cancer biomarkers.
 
Financial terms of the agreement were not disclosed.

Filed under

Informatics
Breaking News
The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.